➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: June 6, 2020

DrugPatentWatch Database Preview

Details for Patent: 5,886,039

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,886,039
Title: Method and composition for treating erectile dysfunction
Abstract:Lipophilic active substance composition and its use in a new method of treating erectile dysfunction by administration thereof, optionally together with a hydrophilic vehicle and optionally an antibacterial agent into the urethra.
Inventor(s): Kock; Nils G. (Goteborg, SE), Lycke; Gerhard (Vastra Frolunda, SE)
Application Number:08/485,041
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 5,886,039

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,886,039

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden8803087Sep 02, 1988

International Family Members for US Patent 5,886,039

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 91886   Start Trial
Australia 4199489   Start Trial
Australia 638414   Start Trial
Canada 1335346   Start Trial
Germany 68907909   Start Trial
Denmark 175560   Start Trial
Denmark 36491   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.